Patent details

EP2079835 Title: COMPOSITIONS AND METHODS OF USING CHONDROITINASE ABCI MUTANTS

Basic Information

Publication number:
EP2079835
PCT Application Number:
PCT/US/2007/081001
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP078539160
PCT Publication Number:
WO/2008/045970
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
COMPOSITIONS AND METHODS OF USING CHONDROITINASE ABCI MUTANTS
French Title of Invention:
COMPOSITIONS ET PROCÉDÉS D'UTILISATION DE MUTANTS DES CHONDROÏTINASES ABCI
German Title of Invention:
ZUSAMMENSETZUNGEN UND VERFAHREN ZUR VERWENDUNG VON CHONDROITINASE-ABCI-MUTANTEN
SPC Number:

Dates

Filing date:
10/10/2007
Grant date:
26/03/2014
EP Publication Date:
26/03/2014
PCT Publication Date:
17/04/2008
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
22/07/2009
EP B1 Publication Date:
26/03/2014
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
10/10/2014
Expiration date:
10/10/2027
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
10/10/2007
 
 

Name:
Acorda Therapeutics Inc.
Address:
420 Saw Mill River Road, Ardsley, NY 10502, United States (US)

Inventor

1

Name:
IACI Jennifer
Address:
United States (US)

2

Name:
VECCHIONE Andrea
Address:
United States (US)

3

Name:
CAGGIANO Anthony, O.
Address:
United States (US)

Priority

Priority Number:
828800 P
Priority Date:
10/10/2006
Priority Country:
United States (US)

Classification

Main IPC Class:
C12N 9/88;
Filing date Document type Number of pages